PR9.BK SET
Praram 9 Hospital Public Company Limited
1W: -2.1%
1M: -2.1%
3M: +2.7%
YTD: -3.1%
1Y: -23.1%
3Y: +10.7%
5Y: +101.9%
฿18.90 ($0.56)
+0.10 (+0.53%)
Weekly Expected Move ±3.0%
฿18
฿18
฿19
฿19
฿20
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ETF Exposure
Income Trends
Revenue
$5.3B
+13.8% ▲
5Y CAGR: +15.2%
Gross Profit
$1.9B
+18.6% ▲
5Y CAGR: +21.5%
Operating Income
$898M
+11.1% ▲
5Y CAGR: +31.9%
Net Income
$823M
+15.4% ▲
5Y CAGR: +32.4%
EPS (Diluted)
$1.05
+15.4% ▲
5Y CAGR: +32.2%
EBITDA
$1.2B
+3.6% ▲
5Y CAGR: +22.6%
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | $3.0B | $4.1B | $4.2B | $4.6B | $5.3B |
| YoY Growth | +14.8% | +37.5% | +2.3% | +10.3% | +13.8% |
| Cost of Revenue | $2.2B | $2.7B | $2.8B | $3.0B | $3.4B |
| Gross Profit | $815M | $1.4B | $1.4B | $1.6B | $1.9B |
| Gross Margin | 27.3% | 33.7% | 32.9% | 34.3% | 35.7% |
| R&D Expenses | $0 | $0 | $0 | $0 | $0 |
| SG&A Expenses | $557M | $735M | $774M | $837M | $988M |
| Operating Expenses | $531M | $707M | $724M | $782M | $988M |
| Operating Income | $297M | $692M | $659M | $808M | $898M |
| Operating Margin | 9.9% | 16.8% | 15.7% | 17.4% | 17.0% |
| Interest Expense | $479K | $480K | $637K | $492K | $764K |
| Income Before Tax | $300M | $700M | $689M | $862M | $1.0B |
| Tax Expense | $51M | $132M | $131M | $149M | $191M |
| Net Income | $249M | $568M | $558M | $713M | $823M |
| Net Margin | 8.3% | 13.8% | 13.3% | 15.4% | 15.6% |
| EPS (Diluted) | $0.32 | $0.72 | $0.71 | $0.91 | $1.05 |
| EBITDA | $590M | $991M | $941M | $1.2B | $1.2B |
| Shares Outstanding | 786M | 786M | 786M | 786M | 786M |